An FDA panel is weighing the pros and cons of a $14K-a-year drug for people at high risk for HIV http://on.wsj.com/KHC9dV
9:05 AM - 7 May 2012
3 replies
24 retweets
4 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.